<html xmlns="http://www.w3.org/1999/xhtml" xmlns="http://www.w3.org/1999/xhtml">
 <head xmlns="http://www.w3.org/1999/xhtml">
 <title xmlns="http://www.w3.org/1999/xhtml"></title>
 </head>
 <body xmlns="http://www.w3.org/1999/xhtml">
 
 Research and Markets has announced the addition of the <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.researchandmarkets.com/research/2qpkqr/latin_america" rel="nofollow" rel="nofollow">&#34;Latin 
 America: Regulatory Compliance Requirements for Life Science Products 
 BRAZIL Mexico, Argentina))): 2-day In-person Seminar&#34;</a> 
 conference to their offering.
 
 
 This two-day comprehensive Course on Latin America Regulatory compliance 
 requirements will cover topics ranging from pre-clinical and clinical 
 requirements through product registration, amendments and renewals 
 across Pharmaceuticals, Biologics, Medical Devices and Combination 
 Products. The Course will address the structure of the regulatory 
 agencies in Latin America and discuss local cultural nuances to help you 
 be successful in working with the regulators.
 
 
 This course specifically focuses on the overall regulatory compliance 
 requirements and procedures for Pharmaceuticals, Medical Devices, 
 Biologics and Combination Products in Latin America. The primary 
 countries covered will include: Argentina, Brazil and Mexico. Other 
 countries such as Chile, Costa Rica, Dominican Republic, Panama, Peru 
 and Venezuela will be discussed. The course will cover topics relating 
 to pre-clinical and clinical requirements, as well as, addressing the 
 structure of the regulatory agencies in Latin America. Content will 
 include descriptions of the methods by which regulators in the 
 corresponding agencies process filings and registrations and what is 
 expected in the authorization and dossier maintenance of the wide array 
 of licensed products.
 
 
 The current regulatory climate in Latin America is discussed in detail 
 and several examples will be provided to illustrate effective compliance 
 procedures and techniques. Common issues that have caused difficulties 
 for Life Sciences firms in the region are outlined. Course content will 
 explain how Latin America interacts with and utilizes ICH standards and 
 how they relate with other National Healthcare Authorities. 
 Additionally, participants will learn how personnel can best address the 
 conflicts, which arise and the best course for resolution.
 
 
 Who Should Attend:
 
 
 - Regulatory personnel whose responsibilities require knowledge of Latin 
 America&#39;s regulatory environment
 
 
 - Administrative staff responsible for ensuring compliance with 
 regulatory filings and overall regulatory compliance requirements will 
 also find this training highly relevant.
 
 
 - QA / QC Personnel
 
 
 - Global Supply Chain personnel
 
 
 - Clinical / Pharma &amp; Device personnel
 
 
 - Manufacturing personnel
 
 
 - Global Business Development personnel
 
 
 - Any sales or general management employee requiring an understanding of 
 how regulations and compliance issues impact the organization
 
 
 For more information about this conference visit <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.researchandmarkets.com/research/2qpkqr/latin_america" rel="nofollow" rel="nofollow">http://www.researchandmarkets.com/research/2qpkqr/latin_america</a>
 
 
 
 <img xmlns="http://www.w3.org/1999/xhtml" alt="" src="http://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20170307005712r1&amp;sid=benz2&amp;distro=nx&amp;lang=en"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.businesswire.com/news/home/20170307005712/en/" rel="nofollow" rel="nofollow">http://www.businesswire.com/news/home/20170307005712/en/</a></body></html>

Press Releases

Two Day Latin America Regulatory Compliance Requirements for Life Science Products Seminar - Focus on Brazil, Mexico, Argentina (New Orleans, LA, United States - May 18-19, 2017) - Research and Markets 

BRAZIL

Two Day Latin America Regulatory Compliance Requirements for Life Science Products Seminar - Focus on Brazil, Mexico, Argentina (New Orleans, LA, United States - May 18-19, 2017) - Research and Markets

TYO:6723


Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced the consolidated financial forecasts for the six months ending June 30, 2024.


Renesas Electronics

Renesas Announces Consolidated Forecasts

AHKSY

TYO:3407


Asahi Kasei announced today that it will construct an integrated plant in Ontario, Canada for the base film manufacturing and coating of Hipore™ wet-process lithium-ion battery (LIB) separator1. In relation to

Asahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada


Renesas Electronics Corporation (TSE:6723) today announced consolidated financial results in accordance with IFRS for the three months ended March 31, 2024.


Summary of Consolidated Financial Results (Note

Renesas Reports Financial Results for the First Quarter Ended March 31, 2024


Orion Group (&#34;Orion&#34;), a commercial and industrial field services company backed by Alpine Investors (&#34;Alpine&#34;), announced today that it has partnered with Academy Locksmith (&#34;Academy&#34;). Academy provides mechanical and

Orion Group&#39;s Facilities Maintenance Business Enters Lock, Door, Safe, and Access Control Market Through Partnership with Academy Locksmith


Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of HashiCorp Inc. (NASDAQ:HCP) to IBM for $35.00 per share in cash is fair to HashiCorp shareholders.


Halper Sadeh encourages HashiCorp

HCP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of HashiCorp Inc. Is Fair to Shareholders


Highlights for the first quarter of 2024 as compared to the first quarter of 2023:



Revenue increased by 20%.



Operating income increased by 42%.



Net income attributable to the Company increased by 34%.



The